La Jolla Pharmaceutical Shares Surge on Positive Trial Results
La Jolla Pharmaceutical shares surged after the micro-cap biotech said late Monday that its study for a chronic kidney disease treatment showed a statistically significant improvement.
La Jolla Pharmaceutical shares surged after the micro-cap biotech said late Monday that its study for a chronic kidney disease treatment showed a statistically significant improvement.
Due to its greater reach along the U.S. East Coast arising from its recent merger with US Airways, American Airlines said Monday that it has ended its inline agreements with JetBlue Airways. It also…
In a new research report, Cowen analysts posted a list of some of the top new datapoints cited at the Cowen 2014 Healthcare Conference by large cap pharmaceutical companies concerning upcoming events and drugs.
ThinkstockThe amount of global debt swelled to more than $100 trillion last year, according to the Swiss-based Bank for International Settlements (BIS), as governments borrowed to lift their economies out of recession and corporations…
In the wake of recent high-profile data breaches, Visa and MasterCard said Friday that they have formed a new group aimed at improving payment system security. The new group will include banks, retailers and…
Less than three months after its rebirth, American Airlines is on pace for a record annual profit estimated at $3.5 billion putting it ahead of rivals Delta Air Lines and United Continental.
The biotech and specialty pharmaceutical groups got hit hard Thursday for a variety of reasons. The largest of which the analysts at Jefferies believe, is commentary within Washington's new budget proposal regarding tax inversion…
After a rough couple of days for investors in McDermott International, a ray of sunshine Thursday following the announcement that the the engineering and construction specialist for the oil industry won a large contract.
Activist investor Carl Icahn has "not yet begun to fight" according to his latest open letter to the shareholders of eBay. His impetus was an investor survey that showed 55% of respondents support a…
As the Wi-Fi market continues its run to be everywhere and ubiquitous, the top companies providing seamless and scalable delivery for their customers will continue to dominate. These are Oppenheimer's top stocks in the…
Here are the four top names added to the Credit Suisse Top Picks list. Investors with a long-term stock horizon should do very well by adding any or all of them to a diversified…
The Institutional Portfolio team at Oppenheimer has run their screens looking for the stocks that can outperform over the next 30 days. Here are some of the best ideas for March from Oppenheimer.
Morgan Stanley reportedly is considering its options, including a possible outright sale, for its private Swiss private banking business. Other international banks have also offloaded their Swiss operations recently.
In separate reports, Comcast said it would indefinitely extend low-cost broadband service to poor families, and that it has begun to expand its Wi-Fi network to homes in the Chicago area.
A new report from the analysts at Baird highlights their top stock ideas for the month of March. Technology stocks dominate the Baird list of best ideas for March. A a surge in demand…
In a new research report, the bank analysts at Deutsche Bank really do the deep-dive to find out which names are good for investors to buy now. Deutsche Bank has limited its top names…
If interest rates stay relatively benign going into the traditional big spring and summer selling time, homebuilders could be looking forward to a strong second and third quarter. J.P. Morgan analysts have three stocks…
CEO Jeff Immelt of General Electric has demonstrated his confidence in the industrial conglomerate by investing his entire 2013 cash bonus in GE shares. This comes in a transitional time for GE.
Intel has made the latest move in wearables by reportedly acquiring smartwatch maker Basis Science. The details were not revealed, but it is believed to have cost Intel between $100 million and $150 million.
After falling more than 10% in after-hours trading on Monday, shares of McDermott International were still down sharply Tuesday morning. This after quarterly results disappointed and the company withdrew its previous guidance.